Plastics In Personalized Drug Delivery Systems Market Share, Size and Outlook 2034
Plastics In Personalized Drug Delivery Systems Market Growth, Size, Trends Analysis- By Type, By End Use - Regional Outlook, Competitive Strategies and Segment Forecast to 2034
| Published: Oct-2025 | Report ID: CHEM25182 | Pages: 1 - 232 | Formats*: |
| Category : Chemical & Materials | |||
Plastics In Personalized Drug Delivery Systems Market Introduction and Overview
According to SPER Market Research, the Global Plastics In Personalized Drug Delivery Systems Market is estimated to reach USD 5.69 billion by 2034 with a CAGR 11.07%.
The report includes an in-depth analysis of the Global Plastics In Personalized Drug Delivery Systems Market, including market size and trends, product mix, Applications, and supplier analysis. The global Plastics In Personalized Drug Delivery Systems Market was valued at USD 1.99 billion in 2024 and is expected to grow at a CAGR of over 11.07% from 2025 to 2034. Continuous innovations in polymer chemistry are driving the development of advanced, biocompatible, and responsive plastics for targeted drug delivery. These materials improve drug stability, controlled release, and patient adherence, fueling market growth. The personalized drug delivery systems industry is increasingly adopting smart polymers that respond to physiological cues like pH, temperature, and enzymes, enabling precise, time-controlled release. Biodegradable and bioresorbable plastics are gaining traction, reducing the need for device retrieval. Integration with nanotechnology, such as polymeric nanoparticles and microneedle patches, is further enhancing patient-centric, next-generation therapeutic solutions.
By Type:
Polylactic acid (PLA) leads the personalized drug delivery plastics market, driven by growing regulatory focus on sustainable medical materials. As a biodegradable and bioabsorbable polymer, PLA supports environmental goals while ensuring patient safety. Its use is expanding in single-use, biocompatible drug carriers, including injectable nanoparticles, microspheres, and transdermal patches. Pharmaceutical and medical device companies are increasingly adopting PLA-based solutions to meet stringent EU and FDA biocompatibility standards. Meanwhile, poly(lactic-co-glycolic acid) (PLGA) is gaining demand for long-acting injectable therapies due to its biodegradability, controlled release, and suitability for sustained-release drugs, protein therapeutics, and vaccines.
By End Use:
The pharmaceuticals and drug delivery segment leads the personalized drug delivery plastics market, driven by the growing adoption of nano-enabled drug delivery systems. Innovations in polymeric nanocarriers, such as liposomes, dendrimers, and polymeric micelles, are enhancing drug solubility, bioavailability, and cellular uptake. Biotech companies are investing in smart polymeric matrices to improve drug encapsulation, targeted release, and patient adherence. Strategic collaborations between pharmaceutical and material science firms are accelerating the commercialization of plastic-based nano-formulations, supporting rapid market growth and meeting the rising demand for precision medicine and biologics.
Regional Insights:
Asia Pacific leads the global personalized drug delivery plastics market, driven by growing adoption of precision medicine and advancements in polymer engineering. The region’s expanding pharmaceutical and biotech industries, particularly in India, Japan, and South Korea, are fostering innovations in smart, stimuli-responsive polymeric carriers for targeted and controlled drug release. Rising chronic disease prevalence, an aging population, and government-supported healthcare digitization are fueling investments in next-generation polymeric delivery technologies, including self-regulating implants and microfluidic polymer dispensers. This positions Asia Pacific as a high-growth hub for advanced drug delivery solutions.
Market Competitive Landscape:
The Plastics In Personalized Drug Delivery Systems Market is highly consolidated. Some of the market key players are Arkema, Avient Corporation, BASF SE, Celanese Corporation, Corbion, DSM, DuPont de Nemours, Inc., Eastman Chemical Company, Evonik Industries, Lubrizol Corporation.
Recent Developments:
In November 2024, Avantium and SCGC expanded their collaboration to accelerate the development of PLGA polyester, a biodegradable and recyclable material. They entered a multi-year agreement to pilot PLGA production using Avantium's Volta Technology, which transforms CO2 into glycolic acid, an essential component of PLGA.
In July 2023, CD Bioparticles launched a new PLGA-based drug delivery line for in vitro and in vivo use. The biocompatible, biodegradable nanoparticles feature various surface modifications to protect drugs, enhance delivery, and improve biological interactions. The range includes Streptavidin-Coated PLGA, Functionalized PLGA, and Functionalized Fluorescent Magnetic PLGA nanoparticles.
Scope of the report:
| Report Metric | Details |
| Market size available for years | 2021-2034 |
| Base year considered | 2024 |
| Forecast period | 2025-2034 |
| Segments covered | By Type, By End Use |
| Regions covered | North America, Latin America, Asia-Pacific, Europe, Middle East & Africa |
| Companies Covered | Arkema, Avient Corporation, BASF SE, Celanese Corporation, Corbion, DSM, DuPont de Nemours, Inc., Eastman Chemical Company, Evonik Industries, Lubrizol Corporation. |
Key Topics Covered in the Report
- Global Plastics In Personalized Drug Delivery Systems Market Size (FY’2021-FY’2034)
- Overview of Global Plastics In Personalized Drug Delivery Systems Market
- Segmentation of Global Plastics In Personalized Drug Delivery Systems Market By Type {(Polylactic Acid (PLA), Poly(lactic-co-glycolic acid) (PLGA), Polyethylene Glycol (PEG), Polyurethane (PU), Polyether Ether Ketone (PEEK), Others)}
- Segmentation of Global Plastics In Personalized Drug Delivery Systems Market By End Use (Pharmaceuticals & Drug Delivery, Medical Devices & Implants, Contract Manufacturing & Drug Formulation Services, Healthcare & Clinics, Others)
- Statistical Snap of Global Plastics In Personalized Drug Delivery Systems Market
- Expansion Analysis of Global Plastics In Personalized Drug Delivery Systems Market
- Problems and Obstacles in Global Plastics In Personalized Drug Delivery Systems Market
- Competitive Landscape in the Global Plastics In Personalized Drug Delivery Systems Market
- Details on Current Investment in Global Plastics In Personalized Drug Delivery Systems Market
- Competitive Analysis of Global Plastics In Personalized Drug Delivery Systems Market
- Prominent Players in the Global Plastics In Personalized Drug Delivery Systems Market
- SWOT Analysis of Global Plastics In Personalized Drug Delivery Systems Market
- Global Plastics In Personalized Drug Delivery Systems Market Future Outlook and Projections (FY’2025-FY’2034)
- Recommendations from Analyst
1. Introduction
- 1.1. Scope of the report
- 1.2. Market segment analysis
2. Research Methodology
- 2.1. Research data source
- 2.1.1. Secondary Data
- 2.1.2. Primary Data
- 2.1.3. SPERs internal database
- 2.1.4. Premium insight from KOLs
- 2.2. Market size estimation
- 2.2.1. Top-down and Bottom-up approach
- 2.3. Data triangulation
3. Executive Summary
4. Market Dynamics
- 4.1. Driver, Restraint, Opportunity and Challenges analysis
- 4.1.1. Drivers
- 4.1.2. Restraints
- 4.1.3. Opportunities
- 4.1.4. Challenges
5. Market variable and outlook
- 5.1. SWOT Analysis
- 5.1.1. Strengths
- 5.1.2. Weaknesses
- 5.1.3. Opportunities
- 5.1.4.Threats
- 5.2. PESTEL Analysis
- 5.2.1. Political Landscape
- 5.2.2. Economic Landscape
- 5.2.3. Social Landscape
- 5.2.4. Technological Landscape
- 5.2.5. Environmental Landscape
- 5.2.6. Legal Landscape
- 5.3. PORTERs Five Forces
- 5.3.1. Bargaining power of suppliers
- 5.3.2. Bargaining power of buyers
- 5.3.3. Threat of Substitute
- 5.3.4. Threat of new entrant
- 5.3.5. Competitive rivalry
- 5.4. Heat Map Analysis
6. Competitive Landscape
- 6.1. Global Plastics In Personalized Drug Delivery Systems Market Manufacturing Base Distribution, Sales Area, Product Type
- 6.2. Mergers & Acquisitions, Partnerships, Product Launch, and Collaboration in Global Plastics In Personalized Drug Delivery Systems Market
7. Global Plastics In Personalized Drug Delivery Systems Market, By Type, (USD Million) 2021-2034
- 7.1. Polylactic Acid (PLA)
- 7.2. Poly(lactic-co-glycolic acid) (PLGA)
- 7.3. Polyethylene Glycol (PEG)
- 7.4. Polyurethane (PU)
- 7.5. Polyether Ether Ketone (PEEK)
- 7.6. Others
8. Global Plastics In Personalized Drug Delivery Systems Market, By End Use, (USD Million) 2021-2034
- 8.1. Pharmaceuticals & Drug Delivery
- 8.2. Medical Devices & Implants
- 8.3. Contract Manufacturing & Drug Formulation Services
- 8.4. Healthcare & Clinics
- 8.5. Others
9. Global Plastics In Personalized Drug Delivery Systems Market, (USD Million) 2021-2034
- 9.1. Global Plastics In Personalized Drug Delivery Systems Market Size and Market Share
10. Global Plastics In Personalized Drug Delivery Systems Market, By Region, 2021-2034 (USD Million)
- 10.1. Asia-Pacific
- 10.1.1. Australia
- 10.1.2. China
- 10.1.3. India
- 10.1.4. Japan
- 10.1.5. South Korea
- 10.1.6. Rest of Asia-Pacific
- 10.2. Europe
- 10.2.1. France
- 10.2.2. Germany
- 10.2.3. Italy
- 10.2.4. Spain
- 10.2.5. United Kingdom
- 10.2.6. Rest of Europe
- 10.3. Middle East and Africa
- 10.3.1. Kingdom of Saudi Arabia
- 10.3.2. United Arab Emirates
- 10.3.3. Qatar
- 10.3.4. South Africa
- 10.3.5. Egypt
- 10.3.6. Morocco
- 10.3.7. Nigeria
- 10.3.8. Rest of Middle-East and Africa
- 10.4. North America
- 10.4.1. Canada
- 10.4.2. Mexico
- 10.4.3. United States
- 10.5. Latin America
- 10.5.1. Argentina
- 10.5.2. Brazil
- 10.5.3. Rest of Latin America
11. Company Profile
- 11.1. Arkema
- 11.1.1. Company details
- 11.1.2. Financial outlook
- 11.1.3. Product summary
- 11.1.4. Recent developments
- 11.2. Avient Corporation
- 11.2.1. Company details
- 11.2.2. Financial outlook
- 11.2.3. Product summary
- 11.2.4. Recent developments
- 11.3. BASF SE
- 11.3.1. Company details
- 11.3.2. Financial outlook
- 11.3.3. Product summary
- 11.3.4. Recent developments
- 11.4. Celanese Corporation
- 11.4.1. Company details
- 11.4.2. Financial outlook
- 11.4.3. Product summary
- 11.4.4. Recent developments
- 11.5. Corbion
- 11.5.1. Company details
- 11.5.2. Financial outlook
- 11.5.3. Product summary
- 11.5.4. Recent developments
- 11.6. DSM
- 11.6.1. Company details
- 11.6.2. Financial outlook
- 11.6.3. Product summary
- 11.6.4. Recent developments
- 11.7. DuPont de Nemours, Inc.
- 11.7.1. Company details
- 11.7.2. Financial outlook
- 11.7.3. Product summary
- 11.7.4. Recent developments
- 11.8. Eastman Chemical Company
- 11.8.1. Company details
- 11.8.2. Financial outlook
- 11.8.3. Product summary
- 11.8.4. Recent developments
- 11.9. Evonik Industries
- 11.9.1. Company details
- 11.9.2. Financial outlook
- 11.9.3. Product summary
- 11.9.4. Recent developments
- 11.10. Lubrizol Corporation
- 11.10.1. Company details
- 11.10.2 .Financial outlook
- 11.10.3. Product summary
- 11.10.4. Recent developments
- 11.11. Others
12. Conclusion
13. List of Abbreviations
14. Reference Links
SPER Market Research’s methodology uses great emphasis on primary research to ensure that the market intelligence insights are up to date, reliable and accurate. Primary interviews are done with players involved in each phase of a supply chain to analyze the market forecasting. The secondary research method is used to help you fully understand how the future markets and the spending patterns look likes.
The report is based on in-depth qualitative and quantitative analysis of the Product Market. The quantitative analysis involves the application of various projection and sampling techniques. The qualitative analysis involves primary interviews, surveys, and vendor briefings. The data gathered as a result of these processes are validated through experts opinion. Our research methodology entails an ideal mixture of primary and secondary initiatives.
Frequently Asked Questions About This Report
Plastics In Personalized Drug Delivery Systems Market is projected to reach USD 5.69 billion by 2034, growing at a CAGR of 11.07% during the forecast period.
Plastics In Personalized Drug Delivery Systems Market grew in Market size from 2025. The Market is expected to reach USD 5.69 billion by 2034, at a CAGR of 11.07% during the forecast period.
Plastics In Personalized Drug Delivery Systems Market CAGR of 11.07% during the forecast period.
You can get the sample pages by clicking the link - Click Here
Plastics In Personalized Drug Delivery Systems Market size is USD 5.69 billion from 2025 to 2034.
Plastics In Personalized Drug Delivery Systems Market is covered By Type, By End Use
Asia Pacific is anticipated to have the highest Market share in the Plastics In Personalized Drug Delivery Systems Market.
Arkema, Avient Corporation, BASF SE, Celanese Corporation, Corbion, DSM, DuPont de Nemours, Inc., Eastman Chemical Company, Evonik Industries, Lubrizol Corporation.
The report includes an in-depth analysis of the Global Plastics In Personalized Drug Delivery Systems Market, including market size and trends, product mix, Applications, and supplier analysis
PLACE AN ORDER
Year End Discount
Sample Report
Pre-Purchase Inquiry
NEED CUSTOMIZATION?
Request CustomizationCALL OR EMAIL US
100% Secure Payment
Related Reports
Have a glance of the Report
Our Global Clients
Our data-driven insights have influenced the strategy of 200+ reputed companies across the globe.
